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identiﬁed or were identiﬁed by their clinical nurse as poten-
tially beneﬁtting from the ICPP. Once identiﬁed, care plans are
developed to address patient concerns, psychosocial factors,
physical needs, daily routine, activity, nutrition, abnormal
assessment ﬁndings, nursing interventions, discharge plan-
ning, short and long term goals. Copies of the care plan are
given to the patient and placed with the nursing documenta-
tion to improve communication. Concurrently, monthly ICPP
meetings are conducted with nurse ICPs to identify patients
who need care plans, address challenges faced, and discuss
literature that supports the need for providing patient-
centered care.
Evaluation: The ICPP initiative is evaluated through two
sources, the ﬁrst a ﬁve question quality improvement ques-
tionnaire utilizing Likert Scale responses to determine
patient satisfaction with nurse communication, responsive-
ness, shared decision-making, and the individualized care
plan. In addition, Quarterly analysis includes comparing
Press Ganey Patient Satisfaction scores pre and post ICP
implementation and comparing ICP survey scores to Press
Ganey scores. Quality improvement data collected from June
1st, 2012- December 31st, 2012 will be presented to examine
the efﬁcacy of the ICPP on patient satisfaction scores.
Discussion: The ICPP initiative is a creative, nurse-driven
initiative to address patient satisfaction during prolonged
admissions for SCT treatment and complications. Preliminary
quality improvement data demonstrates improvement in
overall patient satisfaction scores across a 76-bed inpatient
SCT service at an NCI-designated cancer center. The ICPP
process may prove beneﬁcial and adoptable across SCT care
settings in addressing and improving patient satisfaction.504
Managing Skin and Wound Care on a BMT Unit
Bobbie Davis. Blood and Marrow Transplant Unit, Stanford
Hospital and Clinics, Palo Alto, CA
Signiﬁcance & Background: As products and treatments
change forwounds and pressure ulcers, BMT nurses are faced
with the lack of knowledge and comfort to care for these
types of changes. With the development of unit experts
through a hospital supported program our unit recognized
an increased problem with incontinence associated derma-
titis commonly caused by unmanaged diarrhea from treat-
ment. Diarrhea leads to an increase in skin breakdown and
wounds; putting patients at risk for infection and pain. Our
unit also noted that nurses lacked the general knowledge of
how to prevent, stage and treat pressure ulcers as well as
incontinence associated dermatitis.
Purpose: The purpose of the project was to increase the BMT
nurses knowledge and comfort of skin andwound care issues
commonly found on a BMT unit. A special emphasis was
placed on pressure ulcers and incontinence associated
dermatitis.
Interventions: Ongoing education of unit experts was sup-
ported and encouraged by a hospital supported program. A
quarterly newsletter was distributed to staff with reminders
and updates on pressure ulcers and IAD. Staff was mandated
to read the updates. A skin cupboard with supplies and a skin
binder was developed to be used as a resource for nurses. A
checklist was developed to help the nurses comply with
hospital policy for pressure ulcer assessment, documenta-
tion, and management. A twenty minute power point
presentation focusing on pressure ulcers and IAD was
developed and provided to staff at staff meetings and in-
services throughout the year.Evaluation: A survey was sent to the nurses to determine
their knowledge level and comfort on wounds and inconti-
nence associated dermatitis before and after the
interventions.
Discussion: Ongoing development and reinforcement is
needed for BMT nurses to gain comfort and increase their
knowledge with pressure ulcers and IAD. Recruiting and
retaining wound experts is an ongoing issue.505
Examining the Evidence for Frequency of Vital Sign
Monitoring During Transfusion of Blood Products in the
Stem Cell Transplant Patient Population
Karen Terry DeYoung, Truc Vu. Stem Cell Transplant, M. D.
Anderson Cancer Center, Houston, TX
Background: Patients undergoing stem cell transplantation
(SCT) receive copious amounts of blood products during the
course of treatment. This alone can be disruptive to patients
and is further compounded by taking frequent vital signs
during blood transfusions. Current policy on a large SCT unit
is to take routine vital signs every four hours. During blood
transfusions, vital signs are taken at baseline, 10-15 minutes
after initiation, hourly, and 30 minutes after blood adminis-
tration is complete. Such frequent vital sign monitoring
interrupts sleep and the patient's ability to ambulate or
participate in unit activities, consequently affecting inpatient
stay and satisfaction. Additionally, frequent vital signs
monitoring can be uncomfortable for patient and time
consuming for nurses. The decision for the frequency of vital
sign monitoring is arbitrary, as the current policy is not
evidence based. Relying heavily on vital signs may affect
nursing judgment by becoming too focused on measuring
vital signs and overlooking other non-measurable
symptoms.
Aim/Objective: The staff nurses of a SCT unit identiﬁed the
need to examine the evidence in the literature regarding the
optimum frequency of vital sign monitoring for SCT patients
receiving blood products in relationship to the institution's
current policy.
Intervention: An evidenced-based project was developed to
review current evidence on frequency of vital signs for SCT
patients receiving blood products and comparing those
results to the current policy. The literature reviewed suggests
that taking vital signs before blood transfusions, after ﬁfteen
minutes, and upon completion was clinically sound. In
addition, the literature also supported patient observation as
a key method to assess blood transfusion-related reactions
rather than relying on vital signs alone. All literature
reviewed supported taking vital signs at baseline and after
ﬁfteen minutes, as this is the time period in which a reaction
would most likely occur. In addition, better training of staff
was recommended to recognize a blood reaction should it
occur.
Results/Evaluation: Findings were presented to the Nurse
Practice Congress and a decision to form a PACT was made to
investigate making an institutional policy change. A multi-
disciplinary group is meeting to pursue this change in prac-
tice.506
Moving Mobilization Chemotherapy From the Inpatient
to the Outpatient Setting
Lynn Ellison 1, Theresa Latchford 2. 1 Blood Marrow Transplant
Unit Stanford Hospital Clinics Stanford; 2 Nursing Stanford
Hospital Clinics, Los Gatos
FY Infections per 1000 Line Days
2005 5.45
2006 6.35
2007 4.83
2008 4.31
2009 1.98
2010 1.68
2011 0.64
2012 .88
Annual Cumulative 0.61 (9/11-8/12)
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and reducing costs are crucial goals in today's healthcare
environment. Our busy inpatient unit with a full census was
leading to the overnight stays for mobilization chemo-
therapy taking lower priority than admissions for transplant
and readmissions. Mobilization chemotherapy patients were
being postponed and rescheduled to later dates and times
due to a lack of inpatient beds. The constant full census and
projected growth of our BMT program required a permanent
solution.
Purpose: The goal of this project was to determine if cyclo-
phosphamide used for mobilization could safely be admin-
istered in the outpatient setting.
Interventions: A multidisciplinary team including home
pharmacy, nursing staff, ﬁnancial coordinators, CNS and
physicians gathered to brainstorm ideas to address bed
utilization. Shifting cyclophosphamide mobilization to the
outpatient setting appeared to be a viable solution. The
potential risks and beneﬁts of this practice shift were
explored. Physician orders were modiﬁed and educationwas
provided to the outpatient nurses. A date for go live was set
for a three month trial period.
Evaluation: The inpatient night shift nurse phoned patients
on the evening of cyclophosphamide administration to
assess symptoms and symptom management. Patients
completed a symptom experience survey at 24 and 48 hours
post cyclophosphamide administration.
Discussion: Cyclophosphamide for mobilization may be
given safely as an outpatient. To crucial goals of reducing
costs and improving inpatient bed utilization were achieved.507
Sustaining the Gain: A Units Quest to Maintain Signiﬁcant
Catheter Associated Blood Stream Infection (CA-BSI) Rate
Reductions
Kathleen Marie Demmel 1, Laura Flesch 2. 1 Cancer Blood
Diseases Institute Cincinnati Children’s Hospital Cincinnati;
2 Bone Marrow Transplantation and Immunology, Cincinnati
Children's Hospital Medical Center, Cincinnati, OH
Healthcare reform is nationally charging patient safety
initiatives including eliminating catheter associated blood
stream infections (CA-BSI). Historically, a mid-west pediatric
institution's highest CA-BSI rates resided on the Bone
Marrow Transplant (BMT) Unit housing the most severely
immune compromised patients. The complex 24 bed critical
care unit performs over 90 transplants annually with over
70% being allogeneic. In 2006, BMT's CA-BSI rates reached
a high of 6.35 infections per 1,000 catheter days.
Initially, a CA-BSI maintenance bundle developed in the
intensive care unit was introduced. During the ﬁrst year,
a 32% CA-BSI rate reduction occurred.
A multidisciplinary approach utilizing quality improve-
ment methodology was implemented. Key drivers, condi-
tions creating the ideal state for project success, were
established and guided subsequent interventions via a Plan,
Do, Study, Act model. Ongoing interventions addressed
unique challenges of a highly immune compromised pop-
ulation leading to the “Supercharged Maintenance Bundle.”
formation. Over the next two years, an additional 60% rate
reduction was realized leading to a 1.98 infection rate.
Further interventions generated by a national pediatric
immune compromised patient focused collaborative resulted
in 0.64 infections for FY11, an additional 50% two year
decline.
FY12 resulted in an increased rate of 0.88 infections
further challenging the quest to sustain gains and eliminateCA-BSI. Continued multidisciplinary approaches focusing on
high reliability concepts are essential to sustainability.
Speciﬁcally, preoccupation with failure accompanied by an
in-depth infection analysis providing lessons learned help
continually generate heightened awareness to those identi-
ﬁed risk factors and associated preventative strategies. These
actions lead by the bedside nurse, fuel the awareness and
commitment of all caring for a highly complex and vulner-
able patient population leading to the current 0.61 infections
rate.508
Delivering Seamless Education throughout
a Hematopoietic Progenitor Cell Transplant (HPCT) to the
Patient and Caregiver
Jaclyn Renee Gaffney. Hematology/Oncology: Bone Marrow
and Stem Cell Transplant Unit, New York University Langone
Medical Center, New York, NY
Objective: A comprehensive understanding on the part of
the patient undergoing an HPCT and caregiver regarding the
experience during the hospitalization and the follow up care
required.
Background: The process of HPCT can be a complex and
confusing experience for a patient and their caregivers.
Education is often provided in a single session when trans-
plant is the chosen treatment. These sessions can be over-
whelming and therefore much of the information is not
always retained.
Purpose: To decrease feelings of anxiety and increase
compliance by the HPCT patient in order to maintain his/her
well being during the continuum of care.
Interventions: At NYU Langone Medical Center, the patient
is given an educational document titled “Going Home After
Stem Cell Transplant” by the Registered Nurse (RN) at the
clinical cancer center. In collaboration with the outpatient
RN, the inpatient RN continues utilizing this document once
the patient is admitted. Throughout the hospitalization
ample time is allotted with each patient and caregiver to
discuss discharge plans. The admitting inpatient RN assesses
several factors that may inﬂuence learning including
language, literacy, willingness, and emotional well-being.
Patients are continuously instructed at their own pace on
topics pertaining to their disease process and lifestyle
changes. Teaching techniques are individualized to patients
and caregivers and include printed materials, verbal
instruction and return demonstrations. The RN instructs the
patient and caregiver to refer to the post-HPCT discharge
document frequently and encourages them to ask questions
as they arise.
Evaluation: Evaluation of the seamless education process is
currently being conducted by reviewing patient satisfaction
scores speciﬁc to patient education. Patients provide
